| Size | Price | Stock |
|---|---|---|
| 5mg | $165 | In-stock |
| 10mg | $275 | In-stock |
| 50mg | $715 | In-stock |
| 100mg | $1265 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-12970A |
| M.Wt: | 479.06 |
| Formula: | C25H39ClN4O3 |
| Purity: | >98 % |
| Solubility: | DMSO : 50 mg/mL (ultrasonic);H2O : 20 mg/mL (ultrasonic;warming;heat to 60°C);0.1 M HCL : 50 mg/mL (ultrasonic;warming;adjust pH to 2 with HCl;heat to 60°C) |
EPZ020411 hydrochloride is a selective inhibitor of PRMT6 with an IC50 of 10 nM, it has >10 folds selectivity for PRMT6 over PRMT1 and PRMT8. EPZ020411 hydrochloride can be used for the research of cancer[1][2]. IC50 & Target: IC50: 10 nM (PRMT6), 223 nM (PRMT8), 119 nM (PRMT1)[1] In Vitro: EPZ020411 hydrochloride (0-20 μM; 24 h) decreases H3R2 methylation in A375 cells[1]. EPZ020411 hydrochloride (20-40 μM; 6 h) reduces neomycin- and cisplatin-induced cell apoptosis and increases hair cell survival[2]. In Vivo: EPZ020411 hydrochloride (10 mg/kg; i.p. once) reduces neomycin- and cisplatin-induced hearing loss in C57BL/6J wild-type mice with acute ototoxicity model[2].
| Rats IV 1 mg/kg |
Rats SC 5 mg/kg |
|
| CL (mL/min/kg) | 19.7±1.0 | |
| Vss (L/kg) | 11.1±1.6 | |
| t1/2 (h) | 8.54±1.43 | 9.19±1.60 |
| tmax (h) | 0.444 | |
| Cmax (ng/mL) | 844±306 | |
| AUC0-τ (h·ng/mL) | 745±34 | 2456±135 |
| AUC0-inf (h·ng/mL) | 846±45 | 2775±181 |
| F (%) | 65.6±4.3 |
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.